Analysts Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) PT at $52.29
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) has earned an average recommendation of “Moderate Buy” from the nine brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month price […]
More Stories
Palisade Asset Management LLC Acquires 133 Shares of Merck & Co., Inc. (NYSE:MRK)
Palisade Asset Management LLC raised its holdings in Merck & Co., Inc. (NYSE:MRK – Free Report) by 0.5% during the...
L3Harris Technologies, Inc. (NYSE:LHX) Shares Sold by Palisade Asset Management LLC
Palisade Asset Management LLC reduced its position in L3Harris Technologies, Inc. (NYSE:LHX – Free Report) by 1.0% in the 3rd...
Certified Advisory Corp Has $1.70 Million Stock Holdings in QUALCOMM Incorporated (NASDAQ:QCOM)
Certified Advisory Corp lifted its position in shares of QUALCOMM Incorporated (NASDAQ:QCOM – Free Report) by 8.5% in the third...
Cerity Partners LLC Has $91.47 Million Stake in Caterpillar Inc. (NYSE:CAT)
Cerity Partners LLC raised its holdings in Caterpillar Inc. (NYSE:CAT – Free Report) by 10.3% during the 3rd quarter, HoldingsChannel...
Advisors Asset Management Inc. Purchases 13,689 Shares of NIKE, Inc. (NYSE:NKE)
Advisors Asset Management Inc. raised its position in NIKE, Inc. (NYSE:NKE – Free Report) by 39.6% in the 3rd quarter,...
Cerity Partners LLC Has $350.78 Million Stock Position in iShares Russell 1000 Growth ETF (NYSEARCA:IWF)
Cerity Partners LLC raised its holdings in iShares Russell 1000 Growth ETF (NYSEARCA:IWF – Free Report) by 13.2% during the...